Safety and efficacy of encainide for malignant ventricular arrhythmias
- 29 August 1986
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 58 (5), C87-C95
- https://doi.org/10.1016/0002-9149(86)90110-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.Journal of Clinical Investigation, 1984
- The clinical pharmacology of lidocaine congeners - Review of encainide, flecainide, lorcainide and tocainideEuropean Heart Journal, 1984
- New Antiarrhythmic DrugsDrugs, 1981
- Encainide: A new and potent antiarrhythmic agentAmerican Heart Journal, 1980
- Total Suppression of Ventricular Arrhythmias by EncainideNew England Journal of Medicine, 1980
- Suddent cardic death— Management of the patient at riskCurrent Problems in Cardiology, 1980
- Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agentThe American Journal of Cardiology, 1979
- Clinical experience of encainide (MJ 9067): A new anti-arrhythmic drugEuropean Journal of Clinical Pharmacology, 1979
- Management of patients with malignant ventricular arrhythmiasThe American Journal of Cardiology, 1977
- Approaches to Sudden Death from Coronary Heart DiseaseCirculation, 1971